N-octanoyl-dopamine is a potent inhibitor of platelet function

References

• Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65(12)1533–1542
   PubMed Web of Science ®Google Scholar
• Hing A, Hicks M, Gao L, Wilson M, Mackie F, Macdonald PS. The case for a standardised protocol that includes hormone resuscitation for the management of the cadaveric multi-organ donor. Crit Care Resusc 2005; 7(1)43–50
   PubMedGoogle Scholar
• Kotsch K, Ulrich F, Reutzel-Selke A, Pascher A, Faber W, Warnick P, Hoffman S, Francuski M, Kunert C, Kuecuek O, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: A prospective randomized controlled trial. Ann Surg 2008; 248(6)1042–1050
   PubMed Web of Science ®Google Scholar
• Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, Munari M, Boifava S, Cornara G, Della Corte F, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: A randomized controlled trial. JAMA 2010; 304(23)2620–2627
   PubMed Web of Science ®Google Scholar
• Schnuelle P, Yard BA, Braun C, Dominguez-Fernandez E, Schaub M, Birck R, Sturm J, Post S, van der Woude FJ. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant 2004; 4(3)419–26
   PubMed Web of Science ®Google Scholar
• Gottmann U, Notheisen A, Brinkkoetter PT, Yard BA, Waldherr R, Schnuelle P, van der Woude FJ, Braun C. Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats. Transplantation 2005; 79(10)1344–1350
   PubMed Web of Science ®Google Scholar
• Gottmann U, Notheisen A, Brinkkoetter PT, Yard BA, Waldherr R, Schnuelle P, van der Woude FJ, Braun C. Effects of donor pre-treatment with dopamine on graft function after kidney transplantation: A randomized controlled trial. JAMA 2009; 302(10)1067–1075
   PubMed Web of Science ®Google Scholar
• Benck U, Hoeger S, Brinkkoetter PT, Gottmann U, Doenmez D, Boesebeck D, Lauchart W, Gummert J, Karck M, Lehmkuhl HB, et al. Effects of donor pre-treatment with dopamine on survival after heart transplantation: A cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. J Am Coll Cardiol 2011; 58(17)1768–1777
   PubMed Web of Science ®Google Scholar
• Brinkkoetter PT, Song H, Lösel R, Schnetzke U, Gottmann U, Feng Y, Hanusch C, Beck GC, Schnuelle P, Wehling M, et al. Hypothermic injury: The mitochondrial calcium, ATP and ROS love-hate triangle out of balance. Cell Physiol Biochem 2008; 22(1–4)195–204
   PubMedGoogle Scholar
• Hoeger S, Reisenbuechler A, Gottmann U, Doyon F, Braun C, Kaya Z, Seelen MA, van Son WJ, Waldherr R, Schnuelle P, et al. Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int 2008; 21(11)1072–80
   PubMed Web of Science ®Google Scholar
• Cywes R, Mullen JB, Stratis MA, Greig PD, Levy GA, Harvey PR, Strasberg SM. Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury. Transplantation 1993; 56(2)316–323
   Google Scholar
• Laskowski I, Pratschke J, Wilhelm MJ, Gasser M, Tilney NL. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 2000; 5(4)29–35
   PubMedGoogle Scholar
• Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV. Ischemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153(2)557–566
   PubMed Web of Science ®Google Scholar
• Anfossi G, Trovati M. Role of catecholamines in platelet function: Pathophysiological and clinical significance. Eur J Clin Invest 1996; 26(5)353–370
   PubMed Web of Science ®Google Scholar
• De Keyser J, De Waele M, Convents A, Ebinger G, Vauquelin G. Identification of D1-like dopamine receptors on human blood platelets. Life Sci 1988; 42(18)1797–1806
   PubMed Web of Science ®Google Scholar
• Khanna AS, Agrawal AK, Seth PK. 3H-spiroperidol binding sites in blood platelets. Biochem Biophys Res Commun 1987; 146: 983–988
   PubMed Web of Science ®Google Scholar
• Schedel A, Schloss P, Klueter H, Bugert P. The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol 2008; 378: 431–439
   PubMed Web of Science ®Google Scholar
• Ardlie NG, Glew G, Schwartz CJ. Influence of catecholamines on nucleotide-induced platelet aggregation. Nature 1966; 212(5060)415–417
   PubMed Web of Science ®Google Scholar
• Emerson M, Paul W, Page CP. Regulation of platelet function by catecholamines in the cerebral vasculature of the rabbit. Br J Pharmacol 1999; 27(7)1652–1656
   Google Scholar
• Lösel RM, Schnetzke U, Brinkkoetter PT, Song H, Beck G, Schnuelle P, Höger S, Wehling M, Yard BA. N-octanoyl dopamine, a non-hemodyanic dopamine derivative, for cell protection during hypothermic organ preservation. PLoS One 2010; 5(3)e9713
   Web of Science ®Google Scholar
• Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62(9)1153–1161
   PubMed Web of Science ®Google Scholar
• Kerry R, Scrutton MC. Platelet beta-adrenoceptors. Br J Pharmacol 1983; 79(3)681–691
   PubMed Web of Science ®Google Scholar
• Sibley DR, Monsma FJ, Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992; 13(2)61–69
   PubMed Web of Science ®Google Scholar
• Del Principe D, Frega G, Savini I, Catani MV, Rossi A, Avigliano L. The plasma membrane redox system in human platelet functions and platelet-leukocyte interactions. Thromb Haemost 2009; 101(2)284–289
   PubMed Web of Science ®Google Scholar
• Freedman JE. Oxidative Stress and Platelets. Arterioscler Thromb Vasc Biol 2008; 28: s11–16
   PubMed Web of Science ®Google Scholar
• Arthur JF, Qiao J, Shen Y, Davis AK, Dunne E, Berndt MC, Gardiner EE, Andrews RK. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and -independent pathways. J Thromb Haemost 2012; 10: 1133–1141
   PubMed Web of Science ®Google Scholar
• Clutton P, Miermont A, Freedman JE. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation. Arterioscler Thromb Vasc Biol 2004; 24(1)187–192
   PubMed Web of Science ®Google Scholar
• Begonja AJ, Gambaryan S, Geiger J, Aktas B, Pozgajova M, Nieswandt B, Walter U. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 2005; 106(8)2757–2760
   PubMed Web of Science ®Google Scholar
• Krötz F, Sohn HY, Pohl U. Reactive oxygen species: Players in the platelet game. Arterioscler Thromb Vasc Biol 2004; 24: 1988–1996
   PubMed Web of Science ®Google Scholar
• Krötz F, Sohn HY, Keller M, Gloe T, Bolz SS, Becker BF, Pohl U. Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase. Arterioscler Thromb Vasc Biol 2002; 22(12)2003–2009
   PubMed Web of Science ®Google Scholar
• Pignatelli P, Pulcinelli FM, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 2000; 72(5)1150–1155
   PubMed Web of Science ®Google Scholar
• Juste RN, Moran L, Hooper J, Soni N. Dopmaine clearance in critically ill patients. Intensive Care Med 1998; 24: 1217–1220
   PubMed Web of Science ®Google Scholar
• Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC. Platelet functions beyond hemostasis. J Thromb Haemost 2009; 7(11)1759–1766
   PubMed Web of Science ®Google Scholar
• Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, Messmer K. Platelet-endothelial cell interactions during ischemia/reperfusion: The role of P-selectin. Blood 1998; 92(2)507–515
   PubMed Web of Science ®Google Scholar
• Kirk AD, Morell CN, Baldwin WM 3rd. Platelets influence vascularised organ transplants from start to finish. Am J Transplant 2009; 9: 14–22
   PubMed Web of Science ®Google Scholar